Почетна › Карцином на јајниците › Калифорнија › San Francisco
Клинички испитувања за Карцином на јајниците во San Francisco, CA
19 студии за Карцином на јајниците бараат учесници на локации во и околу San Francisco (во радиус од околу 30 милји). Отворете ја студијата за да видите кој може да учествува и како да го контактирате тимот.
Официјален текст на студијата (англиски)
Барате учесници за студија? Истакнете ја на врвот од оваа страница — $99 за 30 дена →
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
Се регрутираФаза 1/2
- Research Site, San Francisco
Distance-Based Exercise to Preserve Function and Prevent Disability
Се регрутира
- Kaiser Permanente-San Francisco, San Francisco
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
Се регрутираФаза 2
- California Pacific Medical Center - Van Ness Campus /ID# 275329, San Francisco
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
Се регрутираФаза 3
- UCSF Medical Center at Mission Bay ( Site 0013), San Francisco
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
Се регрутираФаза 1
- University of California, San Francisco
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Се регрутираФаза 1/2
- UCSF Medical Center-Mission Bay, San Francisco
A Study of Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein Expression
Се регрутираФаза 3
- Site 0115, San Francisco
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Се регрутира
- Kaiser Permanente-San Francisco, San Francisco
- UCSF Medical Center-Mission Bay, San Francisco
A Study of DM002 in Patients With Advanced Solid Tumors
Се регрутираФаза 1/2
- University of California San Francisco Cancer Center, San Francisco
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Се регрутираФаза 3
- California Pacific Medical Center-Pacific Campus, San Francisco
- Kaiser Permanente-San Francisco, San Francisco
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Се регрутираФаза 2
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Се регрутираФаза 2
- 014, San Francisco
Study of Carboplatin and Mirvetuximab Soravtansine in First-Line Treatment of Patients Receiving Neoadjuvant Chemotherapy With Advanced-Stage Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Се регрутираФаза 2
- University of California San Francisco, San Francisco
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Се регрутираФаза 1/2
- UCSF Medical Center at Mission Bay, San Francisco
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
Се регрутираФаза 1/2
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Се регрутираФаза 1/2
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Се регрутира
- Zuckerberg San Francisco General, San Francisco
- Kaiser Foundation Research Institute, San Francisco
- University of San Francisco, San Francisco
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Се регрутираФаза 1
- University of California San Francisco, San Francisco
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Се регрутираНабљудувачка студија
- Massive Bio SYNERGY-AI site, San Francisco
Испитувања за Карцином на јајниците во други градови
- Houston, TX89 студии
- New York City, NY69 студии
- Boston, MA61 студија
- Los Angeles, CA50 студии
- Nashville, TN49 студии
- Arlington, VA46 студии
- Philadelphia, PA44 студии
- Columbus, OH39 студии
- St. Louis, MO38 студии
- Chicago, IL36 студии
- San Antonio, TX31 студија
- Cleveland, OH30 студии
Други студии во San Francisco
- Рак на простата45 студии
- Рак на дојка43 студии
- Рак на бели дробови со не-мали клетки36 студии
- Рак (сите типови)35 студии
- Срцева слабост29 студии
- Метастатски карцином28 студии
- Рак на бели дробови22 студии
- Меланом22 студии
- Карцином на панкреасот20 студии
- Колоректален карцином18 студии
- Кардиоваскуларни болести18 студии
- Глиобластом17 студии
Од ClinicalTrials.gov, податоци преземени 6.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.